VivekKumar IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India

VivekKumar
Dr Vivek Kumar is working as Associate Professor of Nephrology at the Postgraduate Institute of Medical Education and Research at Chandigarh in India. His research interests include epidemiology and outcomes in CKD and AKI. He is an India Alliance Clinical and Public Health Intermediate Fellow (Department of Biotechnology, Government of India and Wellcome Trust, UK). He has experience in setting up multi-centric cohort studies and clinical trials in India.
Upload Picture
https://storage.unitedwebnetwork.com/files/1099/5e15360dc5e75ca34cb2b91cf1e8adf3.jpeg
First Name
Vivek
Last Name
Kumar
Institution
Country.
India

Friday, February 7, 2025

Time Session
9:45 a.m.
11:15 a.m.
Hot Topics From the Tropics
YN
SabineKaram Chair United StatesUniversity of Minnesota
SourabhSharma Chair IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
  • Best Abstract Winner - Basic Science: miRNA Profiling of Urinary Exosomes for Predicting Renal Outcome After Acute Kidney Injury: A Pilot Study
    YN-01
    JaskiranKaur Oral Abstract Presenter IndiaDepartment of Experimental Medicine and Biotechnology
  • Best Abstract Winner - Clinical Science: Randomised Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults With Steroid-Dependent Idiopathic Nephrotic Syndrome
    YN-02
    AndreaAngeletti Oral Abstract Presenter Italy
  • Q and A
    YN-03
  • Everything You Ever Wanted to Know About Tropical Infections and the Kidney
    YN-04
    MythriShankar Speaker IndiaInstitute of Nephrourology
  • Challenges in the Tropics: When CKDu Becomes Less Unknown
    YN-05
    ErangaWijewickrama Speaker Sri LankaFaculty of Medicine, University of Colombo
  • Roundtable Discussion
    YN-06
    BiancaDavidson Speaker South AfricaGroote Schuur Hospital, University of Cape Town
    ErangaWijewickrama Speaker Sri LankaFaculty of Medicine, University of Colombo
    MythriShankar Speaker IndiaInstitute of Nephrourology
    SourabhSharma Speaker IndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India
    VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
Champa Hall 304
2:15 p.m.
3:45 p.m.
HIT! High Impact Clinical Trials – What and Why
HIT1
AndreaViecelli Chair AustraliaUniversity of Queensland
VivekKumar Chair IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
  • Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE)
    HIT1-1
    RajivAgarwal Oral Abstract Presenter United States
  • Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
    HIT1-2
    BradRovin Oral Abstract Presenter United StatesThe Ohio State University
  • Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
    HIT1-3
    KatherineTuttle Oral Abstract Presenter United StatesUniversity of Washington School of Medicine, Division of Nephrology
Brahmkamal Hall - Plenary Hall

Saturday, February 8, 2025

Time Session
9:45 a.m.
11:15 a.m.
Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session
IK03
GirishNarayen Chair IndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India
Hyeong CheonPark Chair Korea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University
Prem PVarma Chair IndiaPrincipal Director
  • What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes?
    IK03-01
    Chi-yuanHsu Speaker United StatesUniversity of California, San Francisco
  • Are Biomarkers in AKI Ready for Prime Time?
    IK03-02
    ChiragParikh Speaker United StatesJohns Hopkins University
  • Community-acquired AKI in the Tropics - Is it a Different Disease?
    IK03-03
    VivekKumar Speaker IndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India
  • Sex as a Biological Variable in the Epidemiology of AKI
    IK03-04
    MarliesOstermann Speaker United KingdomKing's College London
  • Q&A
    IK03-05
Amaltas Hall B101-A